Home›Companies›Biotech & Pharma›OnKure

OnKure, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 3, 2023·Suggest an edit

About OnKure

OnKure is a private company based in Boulder, Colorado. It has reported $123,181,625 raised in ten offerings on Form D since October 2011.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 24, 2023Apr 3, 2023$53,783,369of $60.0M target15$3.5MEquityRule 506(b)Form D ↗
Mar 3, 2021Mar 5, 2021amended Mar 4, 2022$56,649,181fully sold11$5.1MEquityRule 506(b)Form D/A ↗1 earlier filing
Aug 4, 2020Aug 6, 2020amended Sep 30, 2020$1,500,000of $2.0M target2$750KDebt, Convertible Promissory NotesRule 506(b)Form D/A ↗1 earlier filing
Apr 15, 2020Apr 15, 2020$3,236,935of $5.2M target6$539KEquity, Options, Series A-1 Preferred Stock, Common Stock and Warrants to purchase Series A-1 Preferred StockRule 506(b)Form D ↗
Mar 4, 2020Mar 6, 2020$1,000,000of $2.0M target1$1.0MDebt, Convertible Promissory NotesRule 506(b)Form D ↗
Sep 20, 2019Sep 20, 2019$100,000of $2.0M target1$100KDebt, Convertible Promissory NotesRule 506(b)Form D ↗
Feb 6, 2018Feb 8, 2018$4,957,450fully sold16$309KEquityRule 506(b)Form D ↗
Jun 26, 2015Jul 7, 2015amended Jun 8, 2017$855,000of $1.0M target8$106KDebt, Convertible Promissory NotesRule 506(b)Form D/A ↗1 earlier filing
Jun 4, 2013Jun 4, 2013$599,705fully sold2$299KEquity06Form D ↗
Oct 20, 2011Oct 31, 2011amended Apr 9, 2013$499,985fully sold1$499KEquity06Form D/A ↗1 earlier filing
Total, ten offerings$123,181,625

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on OnKure's Form D filed Apr 3, 2023.

AP
Anthony Piscopio
Executive officer and director
RC
AP
IM
Isaac Manke
Director
DW
Duncan Walker
Executive officer
JW
James Winkler
Executive officer
JL
Jason Leverone
Executive officer
KO
Keith Olivia
Secretary

Earlier filings also listed Zhao Guobao (director, last listed Mar 2022), John DeMattei (executive officer, last listed Mar 2022), Xuedong Liu (executive officer and director, last listed Sep 2020), Donna Peak (director, last listed Sep 2020), Zhao Guabao (director, last listed Sep 2019), Joseph Romano (director, last listed Feb 2018) and Ken Peak (executive officer and director, last listed Apr 2013).

Sources

  1. SECOnKure, Inc. Form D, filed Mar 5, 2021
  2. SECOnKure, Inc. Form D, filed Aug 6, 2020
  3. SECOnKure, Inc. Form D, filed Jul 7, 2015
  4. SECOnKure, Inc. Form D, filed Oct 31, 2011
  5. SECOnKure, Inc. filing history